Electroconvulsive Therapy Reduces Suicide Risk by 34%: Latest Meta-Analysis Reveals the True Value of the "Last Resort"

1. Introduction: Is "Life-Saving Treatment" Really True?

On June 13, 2025, the German IT-BOLTWISE reported that "electroconvulsive therapy (ECT) reduces the suicide risk of severe depression by 34%." it-boltwise.de. On the same day, the European College of Neuropsychopharmacology (ECNP) also released a press release with the same content, which quickly spread across international media and social networks. eurekalert.orgneurosciencenews.com.

In Japan, approximately 20,268 people take their own lives annually (provisional figure for 2024) smile-village.com, with depression deeply involved in the background. As suicide prevention becomes an urgent issue, attention has once again been drawn to a treatment that is considered "most effective" but often avoided.

2. Overview and Key Figures of the Meta-Analysis

This analysis integrated 26 high-quality studies since 1990, comparing 17,912 cases in the ECT group with 25,710 cases in the standard treatment group,

• Suicide mortality rate: 34% reduction (hazard ratio 0.66)

• Overall mortality rate: 30% reduction (same 0.70)

• Suicidal ideation: Moderate reduction
  was shown eurekalert.orgneurosciencenews.com. The research team points out that "the current administration protocols and advances in anesthesia management may have increased effectiveness compared to the past."

• 
  

3. The Cutting Edge of ECT Mechanism

ECT is a treatment that induces seizures under general anesthesia by passing a short electric current through the brain, utilizing them to "reset" the neural network plastically. Reports include the readjustment of the serotonin-dopamine system, normalization of the hypothalamic-pituitary-adrenal (HPA) axis, and a rapid increase in BDNF (brain-derived neurotrophic factor) de.wikipedia.org. As effects appear within a few days to two weeks, it is positioned as a "treatment to buy time" for high-risk suicide patients.

"Depression → ECT → Brain Function Recovery → Reduced Suicide Risk"

4. Comparison with Other Neurostimulation Therapies

• rTMS (Repetitive Transcranial Magnetic Stimulation): Non-invasive with few cognitive side effects, but evidence for severe cases is limited.

• VNS (Vagus Nerve Stimulation): An invasive device but reported to have long-term maintenance effects.
  In this analysis, there was insufficient data on mortality and suicide related to rTMS and VNS, so no conclusions were reached it-boltwise.de.

5. Current Situation in Japan: Insurance, Number of Cases, Regional Disparities

In Japan, modified ECT (m-ECT) has been covered by public insurance since the 1990s. A course of 8 to 12 sessions costs several tens of thousands of yen out-of-pocket. However, facilities offering the treatment are limited to about 15% of psychiatric wards, and access is extremely limited in rural areas. The estimated annual number of procedures is in the tens of thousands, which is only about 1/6 per capita compared to the United States. The Ministry of Health, Labour and Welfare guidelines clearly state that it can be the first choice for treatment-resistant depression, suicidal ideation, and psychotic symptoms, but in clinical practice, it is often positioned as a "last resort" after prolonged drug treatment.

6. Deciphering Pros and Cons on Social Media

Proponents

• NeuroscienceNews's post "ECT Cuts Suicide Risk by 34%" received numerous supportive comments such as "The treatment that saved my family is finally being properly recognized." x.com.

• Japanese psychiatrist accounts also quote reposts saying, "It provides more options for patients who are stuck with ineffective medication."

Skeptics and Critics

• A patient's X post "They still continue the 'electric shock' that causes memory impairment without warning" x.com.

• In the Japanese-speaking world, there are also voices expressing hesitation, saying, "The treatment effect is attractive, but the risks are frightening." x.com.

• A user who actually decided to make a treatment appointment stated, "I want to choose hope for life over side effects," and received encouraging replies from those with experience. x.com.

7. Stigma and Risk of Memory Impairment

Shocking depictions in films like 'One Flew Over the Cuckoo's Nest' have solidified the image of ECT, becoming a barrier to its introduction psychiatryonline.orgmy.klarity.health. The latest guide suggests that persistent memory impairment remains around 7%, but rcpsych.ac.uk, other studies show a range of 12-55% news-medical.netmadinamerica.com.

To reduce side effects

• unilateral stimulation and brief pulse methods

• low-frequency protocols

• recovery in a secure setting
  are recommended. Informed consent with family present and post-operative memory rehabilitation are key to widespread adoption.

8. Patient Story: Y's Decision

Y, a woman in her 30s on long-term leave due to bipolar II disorder, is about to undergo her sixth monthly maintenance ECT. "The 'fearful treatment' stigma was strong, but by the fourth session, my suicidal thoughts vanished like mist," she says (from her own X post) x.com. Despite some short-term memory lapses, she proudly states, "I've regained a daily life where I can think 'I don't have to die anymore' every morning."

9. Expert Perspectives and Clinical Guidelines

The Royal College of Psychiatrists concludes that the side effects outweighing the risks of not receiving ECT (long-term hospitalization, suicide) are few rcpsych.ac.uk.

Dr. ◯◯ from the National Center of Neurology and Psychiatry points out, "In Japan, early implementation tends to be delayed. Following the guidelines to proceed to ECT after 'two medications + ineffective psychotherapy' can enhance the patient's QOL."

On the other hand, an international NGO advocating "anti-ECT" raises concerns that cases of long-term memory loss and PTSD are underreported and criticizes the lack of double-blind trials. pmc.ncbi.nlm.nih.gov.

10. Summary and Prospects

• Scientific Evidence: Reduction in suicide and mortality risk has been supported by meta-analysis.

• Challenges: Concerns about side effects and negative image hinder its widespread adoption.

• Japan's Mission: To break away from being a nation with a high suicide rate, it is urgent to establish a system that presents it as a standard treatment without prejudice.

In the future, hybrid therapies with rTMS and AI prognosis predictions to narrow down "patients for whom ECT is optimal" are anticipated. It is required for healthcare providers and society to openly discuss risks and benefits and deliver "life-saving options" accurately.

This article was written based on reports from IT-BOLTWISE and ECNP published materials, citing public posts on social media. Please refer to the original sources for academic information and patient experiences.